Catalan separatist leader Marta Rovira (Twitter/Catalan News) 
World

Leading Catalan separatist Marta Rovira walks free on bail

Rovira is the deputy leader of the leftwing separatist ERC party, whose chief Oriol Junqueras has been in custody since November.

From our online archive

MADRID: A Spanish judge on Monday allowed leading Catalan separatist Marta Rovira, who faces charges over her region's independence bid, to walk free but ordered her to post bail of 60,000 euros ($75,000), a source close to the case said.

Judge Pablo Llarena placed Rovira under judicial control, but stopped short of putting her behind bars for the duration of an ongoing probe into charges of rebellion, sedition and misuse of public funds.

Rovira is the deputy leader of the leftwing separatist ERC party, whose chief Oriol Junqueras has been in custody since November.

Junqueras was jailed after Madrid ousted his government and dissolved the Catalan parliament, following a failed declaration of independence on October 27.

Catalonia's deposed president, Carles Puigdemont, travelled to Belgium where he has gone into self-imposed exile -- evading a similar fate to Junqueras and three other jailed secessionist leaders.

Rovira was questioned Monday over accusations that she participated in meetings seeking to set out a "road map" plan for Catalan independence.

She told the judge that she attended the meetings because Puigdemont had ordered her to, according to the source, who attended Monday's hearing.

Llarena said Rovira must post bail "within a reasonable timeframe", the source added.

Another separatist leader, Marta Pascal, was next up for questioning.

Why the additional declaration linked to Form 6 is facing a legal challenge

SP-Congress alliance faces fresh strain as Akhilesh skips INDIA bloc meet over UP seat-sharing talks

Rahul Gandhi tells CWC to continue 'resistance' against 'match-fixing' of polls through EVM, voters list

Assam Rifles jawan killed in militant attack in Arunachal; security forces intensify ops to arrest killers

SC slams medicine pricing, calls cancer drug’s 10-fold MRP markup ‘carnage’